Get the Stockscreener App
0.629
5.70%
0.0339
Protagenic Therapeutics Inc Stock (PTIX) Forecast
The Protagenic Therapeutics Inc (PTIX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.0371, representing a +64.88% increase from the current price of $0.629. The highest analyst price target is $1.2398, and the lowest is $0.8344.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PTIX Price Target
Average 1.2619
(+100.62% Upside)
Is Protagenic Therapeutics Inc (PTIX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.97 | Neutral |
| STOCH(9,6) | 16.03 | Buy |
| STOCHRSI(14) | 13.25 | Buy |
| MACD(12,26) | -0.00325 | Sell |
| ADX(14) | 40.52 | Buy |
| William %R | -84.70 | Buy |
| CCI(14) | -58.93 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6493
Sell
|
0.6245
Sell
|
| MA20 |
0.6344
Sell
|
0.6296
Sell
|
| MA50 |
0.6214
Sell
|
0.6447
Sell
|
| MA100 |
0.6651
Sell
|
0.7233
Sell
|
| MA200 |
0.9556
Sell
|
0.871
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PTIX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on PTIX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.97 indicates that PTIX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.03 indicates that PTIX is oversold. This indicates that PTIX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.25 indicates that PTIX is oversold. This suggests that PTIX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 40.52 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -58.93 indicates that PTIX is still oversold but not to an extreme extent.
Long-term PTIX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Protagenic Therapeutics Inc financial reports and earnings history, Protagenic Therapeutics Inc (PTIX) stock could reach $3.2446 by 2030, $28.48 by 2040 and $42.04 by 2050. See the projected annual prices until 2050 of the Protagenic Therapeutics Inc stock below:
- Protagenic Therapeutics Inc (PTIX) is expected to reach an average price of $13.58 in 2035, with a high prediction of $13.31 and a low estimate of $13.58. This indicates an $2,060% rise from the last recorded price of $0.629.
- Protagenic Therapeutics Inc (PTIX) stock is projected to chart a bullish course in 2040, with an average price target of $28.80, representing an $4,479% surge from its current level. The forecast ranges from a conservative $4.1966 to a sky-high $28.48.
- Our analysts predict Protagenic Therapeutics Inc (PTIX) to jump 3,031% by 2045, soaring from $20.39 to an average price of $19.69, potentially reaching $20.38. While $20.39 is the low estimate, the potential upside is significant.
- Protagenic Therapeutics Inc (PTIX) stock is expected to climb by 2050, reaching an average of $41.43, a $6,487% jump from its current level. However, a wide range of estimates exists, with high and low targets of $42.04 and $41.75, respectively, highlighting the market's uncertainty.
Protagenic Therapeutics Inc Stock (PTIX) Year by Year Forecast
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2024
Our forecast for PTIX stock price in 2024 now indicates an average price target of $1.9192 with a high forecast of $3.8328 and a low forecast of $0.00567. The average prediction reflects an increase of +205.13% from the last recorded price of $0.629.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $1.3034 | $0.8344 | $1.2398 | +107.22% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2025
Protagenic Therapeutics Inc Stock (PTIX) is expected to reach an average price of $1.5363 in 2025, with a high prediction of $1.7544 and a low estimate of $1.3181. This indicates an +144.24% rise from the last recorded price of $0.629.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.6128 | $1.5426 | $1.3638 | +156.41% |
| February, 2025 | $1.2169 | $1.5725 | $1.3903 | +93.46% |
| March, 2025 | $1.5833 | $1.5207 | $1.5015 | +151.72% |
| April, 2025 | $1.4004 | $1.5106 | $1.4506 | +122.64% |
| May, 2025 | $1.8076 | $1.5238 | $1.5632 | +187.38% |
| June, 2025 | $1.6389 | $1.8989 | $1.6895 | +160.56% |
| July, 2025 | $1.32 | $1.3181 | $1.3687 | +109.85% |
| August, 2025 | $1.6832 | $1.4174 | $1.2872 | +167.60% |
| September, 2025 | $1.4868 | $1.5186 | $1.337 | +136.38% |
| October, 2025 | $1.4955 | $1.5539 | $1.4063 | +137.76% |
| November, 2025 | $1.8844 | $1.5551 | $1.5748 | +199.58% |
| December, 2025 | $1.1042 | $1.6238 | $1.7544 | +75.55% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2026
The predicted value for Protagenic Therapeutics Inc (PTIX) in 2026 is set at an average of $0.92. Estimates vary from a peak of $1.4619 to a trough of $0.378, indicating an +46.26% surge from the present price of $0.629.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.1831 | $1.1831 | $1.0063 | +88.09% |
| February, 2026 | $1.4611 | $1.2329 | $1.2859 | +132.29% |
| March, 2026 | $1.3316 | $1.5116 | $1.4619 | +111.69% |
| April, 2026 | $0.9509 | $1.1106 | $1.0712 | +51.18% |
| May, 2026 | $0.7999 | $0.79 | $0.7199 | +27.16% |
| June, 2026 | $0.681 | $0.7391 | $0.7595 | +8.27% |
| July, 2026 | $0.3282 | $0.4882 | $0.5587 | -47.83% |
| August, 2026 | $0.5224 | $0.378 | $0.4476 | -16.95% |
| September, 2026 | $0.5065 | $0.497 | $0.4672 | -19.48% |
| October, 2026 | $1.2867 | $0.4261 | $0.9657 | +104.57% |
| November, 2026 | $1.1999 | $1.2455 | $1.2094 | +90.76% |
| December, 2026 | $1.089 | $1.1003 | $1.1272 | +73.14% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Protagenic Therapeutics Inc (PTIX) is $2.5733, with a high forecast of $5.1102 and a low forecast of $0.0364. This indicates an +309.11% increase from the last price of $0.629.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.7433 | $0.9333 | $0.9483 | +18.17% |
| February, 2027 | $0.7224 | $0.7322 | $0.6879 | +14.85% |
| March, 2027 | $0.5751 | $0.5816 | $0.6023 | -8.57% |
| April, 2027 | $0.1908 | $0.3308 | $0.3614 | -69.66% |
| May, 2027 | $0.2199 | $0.0797 | $0.5896 | -65.03% |
| June, 2027 | $4.72 | $0.0364 | $4.4036 | +650.40% |
| July, 2027 | $3.1585 | $3.8185 | $3.3796 | +402.15% |
| August, 2027 | $4.077 | $4.0581 | $3.357 | +548.17% |
| September, 2027 | $3.7351 | $3.8559 | $3.8966 | +493.82% |
| October, 2027 | $3.9336 | $3.3344 | $3.4136 | +525.37% |
| November, 2027 | $4.2921 | $4.2332 | $3.5721 | +582.37% |
| December, 2027 | $6.1902 | $4.6717 | $5.1102 | +884.14% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2028
In 2028, Protagenic Therapeutics Inc (PTIX) is projected to reach an average price of $5.7889, with a high projection of $6.3272 and a low estimate of $5.2506. This indicates an +820.34% rise from the last price of $0.629.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.6287 | $5.8491 | $5.6295 | +794.87% |
| February, 2028 | $6.5472 | $6.1283 | $6.2636 | +940.89% |
| March, 2028 | $6.2653 | $6.4457 | $6.3272 | +896.08% |
| April, 2028 | $6.1718 | $6.2426 | $6.1726 | +881.21% |
| May, 2028 | $6.0999 | $6.1691 | $6.1631 | +869.78% |
| June, 2028 | $5.6604 | $5.974 | $5.6816 | +799.91% |
| July, 2028 | $6.1789 | $6.04 | $6.0189 | +882.34% |
| August, 2028 | $5.653 | $6.0214 | $5.9522 | +798.73% |
| September, 2028 | $5.3847 | $5.4363 | $5.1555 | +756.08% |
| October, 2028 | $5.394 | $5.5399 | $5.2748 | +757.55% |
| November, 2028 | $5.1121 | $5.3701 | $5.2225 | +712.74% |
| December, 2028 | $5.2066 | $5.2506 | $5.0518 | +727.76% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2029
The 2029 price forecast for Protagenic Therapeutics Inc Stock (PTIX) is $3.9405 on average, with a high prediction of $5.2687 and a low estimate of $2.6122. This represents an +526.47% increase from the previous price of $0.629.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.4287 | $5.1903 | $5.2687 | +763.08% |
| February, 2029 | $4.4272 | $4.6672 | $5.1284 | +603.85% |
| March, 2029 | $4.4425 | $4.4861 | $4.3436 | +606.29% |
| April, 2029 | $4.7842 | $4.6446 | $4.4682 | +660.61% |
| May, 2029 | $4.2823 | $4.3623 | $4.5839 | +580.82% |
| June, 2029 | $3.5808 | $3.8408 | $3.9848 | +469.29% |
| July, 2029 | $3.5798 | $3.6101 | $3.5196 | +469.13% |
| August, 2029 | $3.1675 | $3.2575 | $3.489 | +403.57% |
| September, 2029 | $2.8247 | $2.8659 | $3.0172 | +349.09% |
| October, 2029 | $2.7741 | $2.8341 | $2.8752 | +341.03% |
| November, 2029 | $2.6076 | $2.8126 | $2.7218 | +314.56% |
| December, 2029 | $3.2911 | $2.6122 | $3.2674 | +423.22% |
Protagenic Therapeutics Inc Stock (PTIX) Price Forecast for 2030
Protagenic Therapeutics Inc Stock (PTIX) is expected to reach an average price of $5.6611 in 2030, with a high forecast of $10.42 and a low forecast of $0.8986. This signifies an +800.02% surge from the last price of $0.629.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.0393 | $3.0892 | $3.2446 | +383.19% |
| February, 2030 | $2.8271 | $2.9543 | $2.9988 | +349.45% |
| March, 2030 | $2.4562 | $2.6665 | $2.5869 | +290.49% |
| April, 2030 | $2.2147 | $2.3447 | $2.3608 | +252.09% |
| May, 2030 | $1.8128 | $1.9828 | $2.1043 | +188.20% |
| June, 2030 | $1.0713 | $1.4213 | $1.7124 | +70.31% |
| July, 2030 | $0.9344 | $1.0001 | $0.8198 | +48.55% |
| August, 2030 | $10.33 | $0.8986 | $10.42 | +1,542% |
| September, 2030 | $9.6072 | $9.7177 | $9.3189 | +1,427% |
| October, 2030 | $9.6744 | $9.9566 | $9.6449 | +1,438% |
| November, 2030 | $8.5521 | $9.3769 | $9.0532 | +1,260% |
| December, 2030 | $8.9098 | $8.9015 | $8.9204 | +1,317% |
1.80%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):